L 163017

an angiotensin II receptor antagonist; has equal affinity for type 1 and type 2 receptors, structure in first source

Also Known As:

6-(benzoylamino)-7-methyl-2-propyl-3-((2'-(N-(3-methyl-1-butoxy)carbonylaminosulfonyl)(1,1')biphenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine; L 163,017; L-163,017; L-163017

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - L 163017: 1
  - Pyridines: 88
    - L 163017: 1

Related Diseases

1.	Hypertension (High Blood Pressure) 12/29/1995 - "L-163,017 also significantly reduces blood pressure in a renin-dependent model of hypertension, similar to an angiotensin converting enzyme inhibitor (Enalapril) and an angiotensin AT1 receptor-selective antagonist (L-159,282). "

Related Drugs and Biologics

1.	Type 1 Angiotensin Receptor
2.	Renin
3.	Enalapril
4.	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)